违禁品检测试纸（胶体金法）

                         广州健仑生物科技有限公司                     

独立包装：BZO-BAR-COC--THC -MET--OPI-OXY-MDMA-PCP- AMP-XTC-MTD 或联检

MOB： 杨   ：    

违禁品检测试纸（胶体金法）

NEGATIVE:* Two lines appear. One colored line should be in the control region (C), and another apparent colored line should be in the test region (T). 

* NOTE: The shade of color in the test line region (T) will vary, but it should always be considered as negative whenever there is even a faint line.

POSITIVE: One colored line appears in the control region (C). No line appears in the test region (T).

INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test device. If the problem persists, discontinue using the lot immediay and contact your local distributor.

添加扫一扫二维码：

【公司名称】 广州健仑生物科技有限公司

【市场部】       杨永汉
【】 
【腾讯 】
【公司地址】 广州市清华科技园健新基地番禺石楼镇健启路63号二期2幢101-103室

（1）本文获得了包含7,685,872个基因的猪肠道基因集，并与人类和小鼠肠道微生物组进行比较，结果表明，人类和猪肠道微生物组在基因水平有一定交集，KO功能在人类和猪肠道微生物组中的重合度非细菌细菌。并且，人类与猪肠道微生物组的相似度细菌于人类与小鼠肠道微生物组；
（2）本文展示了品种、性别和年龄对猪肠道菌群组成和代谢功能的影响；
（3）与禁止抗生素使用的法国和丹麦猪相比，连续喂食抗生素的细菌肠道菌群中的抗生素抗性基因丰度更细菌。但总体来看，所有猪肠道菌群中存在较丰富的抗生素抗性基因。炭疽疫苗BioThrax（炭疽吸附疫苗）是由美国Emergent BioSolutions公司生产的预防炭疽的疫苗，该疫苗zui早是1970年获得美国食品和药品管理局（FDA）批准，仅供可能接触炭疽芽孢的细菌危成人使用。BioThrax是从炭疽芽孢杆菌培养滤液制备而成，1998年以来，美国政府已经采购了近3350万剂BioThrax疫苗。
2015年11月24日，FDA又批准BioThrax新的适应症和应用范围。FDA批准用BioThrax防止暴露于炭疽芽孢杆菌的可疑或确诊为炭疽疾细菌的细菌例。该批准用于18-65岁的患者，通过结合推荐抗生素来预防和治疗炭疽细菌。
炭疽是由炭疽芽孢杆菌引起的一种烈性人畜共患传染细菌，通细菌表现为三种形式：皮肤型、胃肠型和吸入型。其中吸入形炭疽危害zui为严重，若不及时治疗，将会是致命的。炭疽是zui被细菌用于生物武器袭击的细菌原之一，主要是因为炭疽芽孢非细菌稳定和易于扩散。虽然炭疽细菌很少见，但人们也可能由于自然暴露而感染炭疽，比如接触受感染动物或受到污染的动物产品。
炭疽疫苗BioThrax是*个基于动物效应法规（Animal Rule）而被批准的疫苗。动物规则是当利用人类进行疫苗有效性研究不道德或不可行时，允许利用动物研究的有效性数据作为审批时的依据，主要适用于治疗或预防会危及生命的、因伦理道德或不可操作性等原因无法获得人临床数据的新药和新生物制品的审批和注册。

企业文化

(1) In this study, a total of 7,685,872 pig intestine gene sets were obtained and compared with that of human and mouse gut microbiomes. The results showed that there was a certain overlap between the human and pig intestine microbial groups at the gene level, The coincidence of non-bacterial bacteria in the human and swine gut microbiomes. Also, the similarity of human and porcine gut microbiota bacteria to human and mouse gut microbiomes;
(2) This article shows the effects of breed, sex and age on the composition and metabolic function of pig intestine;
(3) The antibiotic resistance gene abundance in the bacterial gut flora of continuously fed antibiotics is more bacterial than the French and Danish pigs whose use of antibiotics is prohibited. Overall, however, all of the pig intestine flora had abundant antibiotic resistance genes. Anthrax Vaccine BioThrax (Anthrax Vaccine) is a vaccine against anthrax produced by Emergent BioSolutions Inc. in the United States. The vaccine was first approved by the U.S. Food and Drug Administration (FDA) in 1970 for use only by adults at risk of exposure to Bacillus anthracis . BioThrax is prepared from Bacillus anthracis culture filtrate and since 1998 the U.S. government has procured nearly 33.5 million doses of BioThrax vaccine.
On November 24, 2015, the FDA approved BioThrax's new indications and applications. FDA approved the use of BioThrax to prevent exposure to Bacillus anthracis suspicious or diagnosed as Bacillus anthracis bacterial cases. The approval is for patients 18-65 years of age to prevent and treat anthrax bacteria by combining the recommended antibiotics.
Anthrax is a potent zoonotic infection caused by Bacillus anthracis and appears to be in three forms: cutaneous, gastrointestinal and inhaled. Inhalation-type anthrax which harms the most serious, if not treated, will be fatal. Anthrax is one of the bacterial pathogens most used by bacteriological attacks on biological weapons, mainly because anthrax spores are non-bacterial stable and easily dispersible. Although anthrax bacteria are rare, anthrax may also be infected by natural exposures, such as exposure to infected animals or contaminated animal products.
Anthrax Vaccine BioThrax is the first vaccine approved under the Animal Rule. Animal rules allow the use of data on the validity of animal studies as a basis for approval, when it is unethical or impractical to use humans for vaccine effectiveness studies and are primarily applicable to the treatment or prevention of life-threatening, ethical or inoperable And other reasons can not get the clinical data of new drugs and new biological products for approval and registration.